Keyphrases
2-h Plasma Glucose
25%
Adenoviral
42%
Adverse Pregnancy Outcomes
25%
Aortic Stenosis
50%
Aortic Valve Disease
25%
BACE2
50%
Bifurcation
50%
COVID-19
50%
During Pregnancy
56%
Elderly People
25%
Fasting Insulin
31%
Fasting Plasma Glucose
25%
Gene Transfer
50%
Genetic Determinants
50%
Genetic Loci
25%
Genetic Risk Score
50%
Genome-wide Association Study
50%
Gestational Diabetes Mellitus
100%
Glucose Metabolism
50%
Glycemic Traits
100%
HKDC1
50%
Hyperglycemia
25%
Hypertrophic Cardiomyopathy
50%
Insulin Secretion
31%
Insulin Sensitivity
25%
Isoenzymes
50%
Left Ventricular Outflow Tract Obstruction (LVOTO)
50%
Left Ventricular Remodeling
50%
Maternal Metabolism
50%
Myosin Heavy Chain (MyHC)
50%
Non-pregnant Women
31%
Novel coronavirus-19
50%
Oral Glucose Tolerance Test
31%
Outflow Obstruction
50%
Post-myocardial Infarction
50%
Pregnant Women
25%
Primary Prevention
50%
Pulmonary Stenosis
50%
Pulmonary Vein
50%
Randomized Controlled Trial
40%
Septal Reduction Therapy
25%
Sinus Node Dysfunction
50%
Statin Prescribing
50%
Statin Therapy
50%
Statins
40%
Transcatheter Aortic Valve Replacement
25%
Type 2 Diabetes Mellitus (T2DM)
31%
Tyrosine Kinase 2 (TYK2)
50%
Vein Reconstruction
50%
Venoplasty
50%
Medicine and Dentistry
Adverse Effect
13%
Aortic Stenosis
50%
Aortic Valve Disease
16%
Calcium Ion
8%
Carboxy Terminal Sequence
8%
Clinician
9%
Congestive Heart Failure
8%
Coronary Artery Ligation
8%
Coronavirinae
50%
Costamere
8%
COVID-19
50%
Echocardiography
8%
Focal Adhesion
8%
Gene Expression
8%
Gene Transfer
50%
Heart Left Ventricle Outflow Tract Obstruction
50%
Heart Ventricle Remodeling
50%
Heavy Meromyosin
50%
Hemodynamic
21%
Hypertrophic Cardiomyopathy
50%
In Vitro
8%
Isoenzyme
50%
Left Anterior Descending Coronary Artery
8%
Left Ventricular Hypertrophy
16%
Medical History
10%
Messenger RNA
8%
Myocardial Infarction
50%
Myocarditis
5%
Obstruction
50%
Obstructive Sleep Apnea
5%
Overall Survival
8%
Percutaneous Aortic Valve Replacement
16%
Perflutren
8%
Permanent Atrial Fibrillation
12%
Primary Prevention
27%
Protein Tyrosine Kinase
8%
Pulmonary Vein
50%
Pulmonary Vein Isolation
12%
Pulmonary Vein Stenosis
50%
Quantitative Reverse Transcription Polymerase Chain Reaction
8%
Randomized Controlled Trial
18%
Reconstructive Surgery
12%
Respiratory Failure
10%
Sinus Bradycardia
15%
Sinus Node Disease
50%
Statin
50%
Stenting
50%
Vein Reconstruction
50%
Ventricular Tachycardia
5%
Western Blot
16%
